Reactions Weekly

, Volume 1583, Issue 1, pp 204–204 | Cite as

Bevacizumab/irinotecan

Diarrhoea, proteinuria, throat swelling and peripheral neuropathy: 3 case reports
Case report
  • 20 Downloads

Reference

  1. Kalra M, et al. Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment after Subsequent Relapse, in Pediatric Low-grade Glioma. Journal of Pediatric Hematology/Oncology 37: e341-e346, No. 6, 6 Aug 2015. Available from: URL: http://doi.org/10.1097/MPH.0000000000000371 - AustraliaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Personalised recommendations